Lucier Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

  • Investors
  • 4

Lucier General Information

Description

Operator of a novel drug development firm intended to manage microvascular diseases to address unmet medical needs. The company specializes in the preclinical development of injectable and oral small-molecule inhibitors for treating microvascular diseases, helping medical clients to improve the diagnosis of coronary microvascular dysfunction and disease.

Contact Information

Website
www.lucierpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 3608 East 29th Street Suite 209
  • Bryan, TX 77802
  • United States
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 3608 East 29th Street Suite 209
  • Bryan, TX 77802
  • United States

Lucier Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lucier Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 13-Oct-2026 In Progress Pre-Clinical Trials
4. Grant 10-Sep-2026 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2026 Completed Startup
2. Accelerator/Incubator 01-Jan-2026 Completed Startup
1. Accelerator/Incubator 01-Jan-2026 Completed Startup
To view Lucier’s complete valuation and funding history, request access »

Lucier Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lucier Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
California State University, Los Angeles University
HBS Alumni Association of the UK Angel Group
Nucleate Accelerator/Incubator
To view Lucier’s complete investors history, request access »

Ready to get started?

Request a free trial

Lucier FAQs

  • When was Lucier founded?

    Lucier was founded in 2022.

  • Where is Lucier headquartered?

    Lucier is headquartered in Bryan, TX.

  • What is the size of Lucier?

    Lucier has 1 total employees.

  • What industry is Lucier in?

    Lucier’s primary industry is Drug Discovery.

  • Is Lucier a private or public company?

    Lucier is a Private company.

  • What is Lucier’s current revenue?

    The current revenue for Lucier is .

  • Who are Lucier’s investors?

    National Institutes of Health, California State University, Los Angeles, HBS Alumni Association of the UK, and Nucleate have invested in Lucier.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process